The 5-HT2 receptor antagonist, pelanserin, inhibits alpha 1-adrenoceptor-mediated vasoconstriction in vitro

Eur J Pharmacol. 1995 Apr 24;277(2-3):181-5. doi: 10.1016/0014-2999(95)00074-u.

Abstract

The antagonism by pelanserin (2,4(1H,3H)-quinazolinedione,3-[3-(4-phenyl-1- piperazinyl)-propyl]-HCl), a potent 5-HT2 receptor antagonist, of alpha 1-adrenoceptor-mediated contractions of endothelium-denuded carotid, aorta, mesenteric and caudal arteries of both normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats was investigated. The selective alpha 1-adrenoceptor agonist methoxamine elicited concentration-dependent contractions in all four arterial rings, an effect which was competitively antagonized by pelanserin. pA2 values for pelanserin were in the 7.67-8.11 range when evaluated against the alpha 1-adrenoceptor agonist in arteries from normotensive or hypertensive rats. These data support the conclusion that pelanserin displays alpha 1-adrenoceptor blocking properties. The ability of the 5-HT2 receptor antagonist pelanserin to additionally block alpha 1-adrenoceptor-mediated constriction in different vessels of WKY and SHR may potentially contribute to its blood pressure lowering effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / drug effects
  • Aorta / metabolism
  • Blood Pressure / drug effects
  • Carotid Arteries / drug effects
  • Carotid Arteries / metabolism
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Hypertension / drug therapy
  • Hypertension / physiopathology
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / metabolism
  • Methoxamine / pharmacology
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects*
  • Quinazolines / administration & dosage
  • Quinazolines / pharmacology*
  • Quinazolines / therapeutic use
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Receptors, Adrenergic, alpha-1 / drug effects
  • Receptors, Adrenergic, alpha-1 / physiology*
  • Serotonin Antagonists / pharmacology*
  • Tail / drug effects
  • Tail / metabolism
  • Vasoconstriction / drug effects*

Substances

  • Quinazolines
  • Receptors, Adrenergic, alpha-1
  • Serotonin Antagonists
  • pelanserin
  • Methoxamine